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The  initial and  prerequisite  event  in  IgE-mediated degranulation  of mast 
cells and basophils is the binding of IgE to the surface membrane of these cells. 
The  binding  appears  to  be  via  the  Fc  region  of  the  immunoglobulin  (1,  2) 
leaving the Fab region free to react with antigens which then trigger degranula- 
tion. 
Very little is known about the cellular receptors to which the Fc region of the 
IgE becomes bound. Our aim is to explore the IgE binding in detail; to study 
the  binding parameters  and  to  isolate and  characterize  the  cellular receptor 
activity for IgE. 
In this paper we present  our initial studies on  a  rat basophil leukemia (3) 
which may be useful in this regard. The leukemic cells deplete reaginic passive 
cutaneous  anaphylaxis  (PCA)  1  activity  from  rat  and  mouse  immune  sera. 
Specific adsorption  of  rat  IgE  immunoglobulins  was  detected  by  the  use  of 
radiolabeled antilight-chain antibodies and IgE. 
Materials and Methods 
Rat Basophll Leukemla.--A litter of 10 ICI Wistar rats (Imperial Chemical Industries, Ltd., 
Macclesfield,  England)  which  had  been  subcutaneously  inoculated at birth with leukemic 
basophils (3) 2 wk earlier, were received by us on 3/20/73. Daily blood smears were monitored 
and when leukemic basophils or tumors appeared the animals were sacrificed, and heparinized 
leukemic blood or minced tumor was transplanted subcutaneously. 
After our initial experience  (see Results)  the following protocol has been routinely used: 
Basophilic  tumor is removed from 2-3-wk old rats and minced in cold Tyrode's buffer  (T). 
This buffer was adjusted to pH 7.6 at room temperature. After filtering through glass wool, 
0.05-0.10 ml of a suspension containing 0.5-1  million cells/ml is inoculated subcutaneously, 
with a 26 gauge X ~/~ inch needle, into the back of the neck of newborn to 48-h old rats. Tumor 
develops in 10-15 days in about 70-80%  of Wistar rats (ICI and WKY/N strains). 
The leukemic cells were adapted to cell culture (see Results).  They are now propagated 
1  Abbre~ations used in this paper: PCA, passive cutaneous anaphylaxis; T, Tyrode's buffer; 
TCM, Tyrode's buffer with 1 mM Ca  ++ and Mg  +÷ . 
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according to the following protocol: Cells are grown in suspension in stationary Falcon flasks 
(Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) andare monitored by media pH, inverted 
microscopy,  and cell counts.  Eagle's Basal No.  2  Media supplemented with  15% heat-in- 
activated fetal calf serum  2 (Grand Island Biological Co., Grand Island, N. Y.), 4 mM ghita- 
mine, 100 U/ml penicillin, and  100 #g/ml streptomycin is used.  50-70% of the medium is 
replaced every 2-3 days maintaining the cell density at 4-10 X  105 cells/ml. 
Mouse Mastocytomas.--LAF1 mice with the ascitic mastocytoma of Furth  (4)  were  ob- 
tained from P.  Minard  and  D.  Levy,  Johns Hopkins  University.  The  tumor was main- 
tained by intraperitoneal (i.p.)  transplantation of aseites every 7-10 days into 6-8-wk old 
LAF1 mice (Jackson Laboratories, Bar Harbor, Maine). 
Two Baib/c mice carrying the P815 ascitic mastocytoma (5)  (generation 314) were pro- 
vided by Dr. M. Potter, NCI, NIH. The tumor was maintained by weekly i.p.  transplanta- 
tion of  0.05-ml  ascites  plus  0.05  mi  Ringer-Locke solution into CDF1  mice  (Balb/C  X 
DBA/2). 
Rat Reaginic Serum.--The pool of serum from rats injected with Nippostrongylus brasiliensis 
which was used in these experiments has been described elsewhere.  3 
Mouse Reaginic Serum.--Mouse  reaginic serum (pool I, Tables I, II, and V) was prepared 
by injecting 2-mo old Swiss mice monthly with 1 #g ovaibumin (2X crystallized, Worthington 
Biochemical Corp., Freehold, N. J.) i.p. according to the method of Levine and Vaz (6).  1-wk 
after the fifth and subsequent injections the animals were bled and the high titered serums 
pooled. This pool had a PCA titer of 1 : 1024. 
A  pool of mouse reaginic serum  (pool II, Table V) from LAF1 mice injected with oval- 
bumin, ovomucoid, lysozyme, benzylpenicilloyl conjugates of bovine IgG, and serum albumin 
was a  gift from Dr.  R. Siraganian, NIDR, NIH. The pool had a  titer  of  1:1,280  vs.  oval- 
bumin and ovomucoid, and a titer of  < 1:160 against the other immunogens. 
Purified Rat  [~5I]IgE.--SubstantiaUy purified  rat  [125I]IgE was  prepared  as  described 
elsewhere (footnote 3). For the experiments described here, preparations in which 65% of the 
counts were serologically identifiable as IgE were routinely used. The preparations contained 
approximately 25-50 #g of [125I]IgE and 200-300/zg of uniodinated ovaibumin/ml. 
An immunoglobulin-depleted preparation of the [l~sI]IgE solution was obtained by passing 
the iodinated material through a rabbit antirat Fab column as described elsewhere (see foot- 
note 3). This material contained 31% of the original counts and by radioimmunoassay only 
~5%  of the counts were precipitable by a goat antirat IgE serum. 
Inactivated Reaginic Serums.--Reaginic  serums were  heat inactivated by  incubation at 
56°C  for 4 h  with complete loss of PCA titer. A  reaginic fraction of rat serum purified by 
fractional ammonium sulfate precipitation, gel filtration, and ion-exchange chromatography  3 
was dialyzed overnight vs. Tris 0.2 M, pH 8.6. One-half of the 1.36-mg sample which contained 
8,000 PCA U  was made 0.01 M  in dithiothreitol, incubated at 37°C for  1 h, subsequently 
made 0.022 M  in iodoacetamide and further incubated for ~  h. The reagents were added in 
the reverse order to another aliquot which served as a  control. Both samples were dialyzed 
against T  overnight. The treated sample had  ~250 PCA U/ml and the control 1,000  PCA 
U/ml. 
Iodinated Rabbit Antirat Light-Chain Antibodies.--The preparation of purified antirat light- 
chain antibodies has been described.  3 F(ab  r) 2 fragments of these antibodies were prepared by 
digesting a 0.85% solution with 2% wt/wt pepsin (Worthington Biochemical Corp, Freehold, 
N. J.) at pH 4.5, 37°C for 16 h  (7).  F(abJ)2 fragments were isolated by chromatography on 
Sephadex G-150 (Pharmacia Fine Chemicals, Inc, Piseataway, N. J.).  Fab  J fragments were 
2 Either "gamma-globulin free" or conventional fetal calf serum have been used with no 
apparent difference in the cell growth. 
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prepared by reducing a  0.42% solution of F(ab')2 fragments with 0.01 M  dithiothreitol at 
pH 8.6 for 1 h and alkylating with 0.022 M iodoacetarnide for 20 rain, all at room temperature. 
Fab' fragments were purified by chromatography on Sephadex G-100. 
The intact antibodies and their fragments were iodinated by a  modification  s of the pro- 
cedure of McConahey and Dixon (8). Approximately 2 X  10  -3 mol 1251  were incorporated/mol 
of protein giving 1.0-1.5  X  10 s cpm/mg when counted in a  Packard  Gamma Scintillation 
Spectrometer (Packard Instrument Co., Inc, Downers Grove, Ill.). 
In order to approximate the antigenic valence of IgE with respect to the [125I]antilight-chain 
antibodies, increasing amounts of the latter were added to a  known amount of rat IgG. The 
complexes were then precipitated with excess rabbit antibodies specific for the Fc region of rat 
IgG. At saturation, approximately 3.5 mol of antilight-chain antibody were bound/mole IgG. 
Reagin Depletion and Binding Stndies.--Depletion and binding studies were performed with 
tumor minces or cultured cells alternatively. When tumors were used necrotic and capsular 
material was removed and the tumor minced in cold T. The suspension was filtered through 
glass wool and the cells washed at least once with cold T. When cultured cells were used they 
were simply centrifuged and washed at least once. In both cases the cells were counted in the 
presence of trypan blue. The tumor minces always contained moderate numbers of broken cells 
and showed only 60-70% viability of the intact cells.  The cultured cells were essentially all 
intact and showed 95-100% viability. 
For PCA depletion studies the cells were incubated with reaginic serum dilutions at 37°C 
and after an appropriate interval sedimented. Dilutions of the supernate were then assessed 
for PCA activity. 
For studies involving the use of rabbit antirat light-chain antibodies, 2  X  106 washed 
minced tumor cells were incubated with serum or buffer for 1 h at 37  °, and then centrifuged 
at 220 g for 15 min. The cells were resuspended in buffer and washed three times. The final 
cell pellet was suspended in an appropriate dilution of [125I]rabbit antibody and incubated for 
15-30 min at 0--4°C. The ceils were again washed two to three times and the final pellet counted. 
The binding of  [125I]IgE was  assessed  either by following  the depletion of  supernatant 
radioactivity or measuring the counts bound to cell pellets. For the depletion studies, the cells 
were washed once in T and then incubated with [x25I]IgE preparations at 37°C  for 60--90 min. 
The cells were sedimented in a  Sero-fuge (Clay-Adams, Inc., New York), for 2 min and mea- 
sured aliquots of the supernates were counted. No corrections were made for  the volume oc- 
cupied  by  the ceils since in most cases  the error introduced by  neglecting  this correction 
was small. 
For the assessment of cell-bound counts, 0.2 ml of cell suspension was layered over 0.2 mi of 
heat-inactivated fetal calf serum in plastic Microfuge tubes and centrifuged in a  Microfuge 
(Beckman Instruments, Inc, Fullerton, Calif., Model 152) for 1 min. Supernatant fluid was 
aspirated and the tip of the tube containing the cell pellet snipped off and counted. The data 
reported in Tables V and VI and Figs. 2 and 3 were collected using this method. 
PCA Measurements.--PCA titers of rat reaginie antibodies to the Nippostrongylus brasilien- 
sis antigens were determined by standard methods  (9).  PCA titers of mouse reaginic anti- 
ovalbumin antibodies were determined in rats. 1/6 ml of a 2% ovalbumin solution was used for 
the antigen challenge. In all cases, the PCA units in 0.1 ml were expressed as the reciprocal of 
the highest dilution giving a  reaction of 7  )<  7 mm or greater. All PCA tests were made at 
least 48 h  after the injection of reagins. 
RESULTS 
Propagation  of Tumor.--Newborn  rats from eight Wistar  strains  (MNR/N, 
MR/N,  NSD/N,  RHA/N,  RLA/N,  SHR/N,  WKY/N,  and  WN/N)  were 
inoculated  with  suspensions  of  minced  tumor  (see  Materials  and  Methods). 
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ing tumors. The clinical picture of leukemia (3) developed in all strains,  and 
elevated peripheral basophils were present in the blood smears of three strains 
monitored (27 %, 47 %, and > 50 % in animals of one litter). 
Transplantation was most successful in the strain of origin, in which 31 of 32 
litters accepted the tumor, compared to 9 of 12 WKY/N litters. In both cases, 
~70%  of the  animals  in positive litters developed tumor  and N20%  were 
found dead or had been cannibalized presumably because leukemia preceded 
the development (or the observation) of tumor. 
4-wk old rats from four strains were given trochar implants of 10 X  2 X  2 mm 
tumor pieces,  taken  (whenever possible)  from  animals  of  the  same  strain. 
Initially, 20 of 25  litters accepted the  transplant  (109 of 175  animals)  with 
tumors developing in 7-12 days, but the tumors decreased in size and many 
disappeared in 15-30 days. 
Cell Culture.--Tumors were removed from 2-wk old rats under sterile condi- 
tions, minced, and washed in the culture media (see Materials and Methods) 
with 1,000 U/ml penicillin and 1 mg/ml streptomycin. After filtration through 
sterile glass wool, 12 ml of a suspension containing 7 X  105 cells/ml were added 
to 30-ml Falcon flasks. After incubation in 10 % CO2 for 2 days, the cells were 
maintained in a 37°C incubator and growth began on the 3rd day. 
In 15 % fetal calf serum the cell doubling time was less  than 48 h  and cell 
densities of 2 X  106 cells/ml could be obtained. Fig. 1 shows a preparation of 
cultured cells 1 mo after initiation of cell culture. 
Depletion  of _PCA by Rat Leukemic  Basophils.--The  capacity of leukemic 
basophils to deplete immune sera of PCA activity was assessed and representa- 
tive experiments are  shown in Table I.  After  1 h  incubation in  either T  or 
Tyrode's buffer with  1  mM  Ca  ++  and  Mg  ++  (TCM)  substantial  depletion 
occurred, approximately 10-20 PCA U  being removed/106 cells. The presence 
of Ca  ++, Mg  ++, and up to 20 % normal rat sentm did not markedly affect this 
depletion. With longer incubation periods thele seems to have been some further 
depletion although we do not have sufficient PCA depletion data to rigorously 
establish this point. As can be seen from Table I  mouse reagins were also de- 
pleted with good efficiency. Since comparative values for PCA units per mole 
of rat and mouse IgE are unknown we cannot directly evaluate the significance 
of the apparent increased PCA depleting capacity of the cells for the mouse 
reagins. 
In separate experiments 7 X  106 cells were incubated in TCM at 37  ° for 120 
rain. The cells were centrifuged and 0.7 ml of the supernate was incubated with 
0.3 ml of diluted rat reaginic serum (160 PCA U/ml). After 60 rain at 37  ° the 
solution was tested. No loss in PCA activity was found. 
Depletion of _PCA by Mouse Mastocytoma  Cells.--For comparative purposes 
the capacity of mouse mastocytoma cells to deplete mouse and rat reagins was 
determined; representative data are given in Table II. The Furth tumor cells 
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FIo.  1.  Cytocentrifuged leukemic basophils from a  suspension cell culture  1 mo after 
initiation of culture. The cells were stained with modified Wright's stain  (Ames Co., Div of 
Miles Lab, Inc, Elkhart, Ind.).  X 880. 
considerably less effective than the rat cells (compare Tables I and II). Included 
in Table II are data published by Minard and Levy (10) ; our results are entirely 
consistent  with  theirs.  These  workers  also  showed  that  the  medium  of  cell 
incubation  mixtures did  not  in  itself deplete  PCA  activity and  we obtained 
similar results. Cells from the mouse mastocytoma P815 failed to exhibit PCA- 
depleting activity. 
Studies with Rabbit AntiRat Light-Chain Antibodies.--Tmnor cell suspensions 
were preincubated with reaginic sera or control solutions, washed, and incubated 
with 12~I-labeled F(ab')2 fragments of rabbit antirat light-chain antibodies. 
Table III (Exp. A)  shows that anfilight-chain  antibody was bound  to cells 
preincubated with reaginic serum, but was bound only minimally to cells prein- 
cubated only with buffer or rat IgG. In separate  experiments (not  shown)  we 
found that the specific binding was not affected by 0.1% decomplemented rat se- 
rum present in the initial wash, by the number of washes  (1-3)  before  prein- 
cubation with reagin, or by the presence of TCM. 
Once incubated with reaginic serum, the cells did not lose their capacity to 
specifically bind antilight-chain  antibody despite repeated washing before  the 
addition of the iodinated antibody (Exp. B, Table III). Part of the small loss 
observed undoubtedly reflects a small loss of cells occurring during the multiple 
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TABLE I 
Depletion of PCA by Rat BasopM1 Leukemia Cells 
Exp.  Cell- Cells/ml  X  Incu-  PCA U/ml  bation con- Species  of PCA 
type*  10-0  ditions~;  Initial  Final  /k 
PCA depleted/ 
10  6 cells 
A  0  1  Rat  20  20  0 
0  40  40  0 
0  160  160  0 
m 
4.9  20  0  20  >4.1 
4.9  40  10  30  6.1 
4.9  160  160  0  (<16) 
8.9  29  0  29  >3.3 
Tu  11  20  0  20  >1.8 
11  40  0  40  >3.6 
11  160  40  120  11 
0  2  Rat  40  40  0 
0  80  80  0 
0  160  160  0 
m 
C  4.7  40  0  40 
4.7  80  20  60 
>8.5 
13 
Tu  2.9  80  28  52 
2.9  160  80  80 
18 
28 
C  --  0  3  Rat  ND§  >320  0 
0  ND  >160  0 
Tu  7.0  ND  80  >240][  >34 
7.0  ND  40  >120]1  >17 
0  3  Mouse  2600  2600  0 
0  640  640  0 
0  160  160  0 
Tu  7.0  2600  <£160  >2400  >340 
7.0  640  <40  >600  >340 
7.0  160  <10  >150  >21 
* C, cultured cells and Tu, tumor mince. 
1  =  TCM buffer plus 0.1% normal rat serum, vol 1 ml, 60 
vol 3 ml, 60 min, 37°C; 3  =  TCM buffer, plus 20% normal rat 
37°C. 
§ ND, not determined. 
[[ Calculated by subtraction from cell-free control. 
min, 37°C; 2  =  T  buffer, 
serum, vol 1 ml,  120 min, 606  IgE-BINDING  BASOPHIL  LEUKEMIA  CELLS 
TABLE II 
Depletion of PCA  by  Mouse  Mastocyloma  Cdls 
Exp.  Cell type* 
Cells/ml X  Species of  PeA U/ml  PCA de- 
pleted/10  e 
10-e  PCA  Initial  Final  /~  cells 
C§ 
Furth 
0  Mouse  40  40  0  -- 
120  80  >40  <40  <0.34 
120  4O  <4O  >0  >0 
240  80  40  40  0.5.7 
240  40  20  20  0.083 
490  80  20  60  0.5.2 
490  40  <20  >20  0.045. 
--  (2)*  0  Mouse  20  20  0  -- 
(2)  0  5.0  5.0  0  -- 
Furth (2)  58  20  10  5.0  0.17 
(2)  58  10  0  5.0  0.17 
(2)  5.15  20  10  5.0  0.087 
(2)  5.15  5.0  0  5.0  0.087 
5.0  Mouse  20--40  20-40  (0)  (0) 
50  20--40  16-32  4-8  0.08-0.16 
5.00  20--40  4-8  16-32  0.08--0.16 
Furth 
--  (2)  0  Rat  20  20  0  -- 
(2)  0  5.0  10  0  -- 
Furth (2)  5.00  40  20  20  0.2 
(2)  5.00  20  5.0  10  0.5. 
(2)  100  10  <5.0  >0  >0 
--  (3)  0  Rat  80  ~80  ~0  -- 
Furth (2)  5.00  80  ~80  ~l  -- 
(2)  200  80  >40  <40  <0.2 
(2)  400  80  40  40  O. 5. 
(2)  800  80  20  60  0.075 
Furth 
P815 
0  Rat  80  80  0  -- 
0  40  40  0  -- 
0  20  ~20  N0  -- 
110  80  >40  <40  <0.36 
110  40  <40  >0  >0 
110  20  10  10  0.091 
ll0  80  80  0  0 
liO  40  40  0  0 
110  20  ~20  ~0  N0 
* Furth mastocytoma cells and 1°815, Dunn-Potter mastocytoma. 
~: Numbers in parentheses indicate duplicates, etc. 
§ Data taken from published results of Minard and Levy (10). 
In Exp.  C, Table III, --~2.2  X  10  6 cells were preincubated with increasing 
numbers of PCA units; corresponding increases in the amount of bound anti- 
light-chain antibodies were found. 
The amount of bound antilight-chain antibodies also was influenced by the 
concentration of the rabbit antibodies to which the cells were exposed (Exp. D, 
Table III). Substantial increases in the amount of rabbit antibody adherent to 
unsensitized cells were also observed at the higher concentrations. 
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TABLE III 
Binding of [  12 si] F (ab ') 2 Fragments of Rabbit A ntilight  - Chain 
Antibodies to Rat Leukemic BoaopMls* 
Exp.  Buffer 
Preincubation  Incubation  Counts bound/cell  X  10  8 
PCA/ml  Washes  Antibodies/vol Washes  Gross  Net 
~g/ml 
A~  TCM  4000  3  6.75/0.9  3  10  9.2 
320  8.6  7.8 
O§  1.8  1.0 
0  0.80  -- 
B  T  320  2  3.75/0.5  3  7.1  5.2 
0  2  1.9  -- 
320  4  6.8  4.9 
0  4  1.9  -- 
320  6  5.8  4.1 
0  6  1.7  -- 
320  8  5.8  4.3 
0  8  1.5  -- 
C  TCM  640  3  7.5/1.0  2  7.6  5.5 
320  6.3  4.2 
224  6.1  4.0 
160  5.3  3.2 
64  4.6  2.5 
32  3.7  1.6 
0  2.1  -- 
D~  T  1600  3  3.75/0.5  2  12  10 
320  10  8.4 
0  1.6  -- 
1600  13.5/0.5  24  19 
320  18  13 
0  4.9  -- 
1600  37.5/0.5  33  22 
320  29  18 
0  II  -- 
* 2.2  X  106 (4-10%)  washed minced tumor ceils were preincubated  at 37°C for  1 h  in 
reaginic serum dilutions or buffer, washed in cold buffer, and incubated at 0-4°C for 15-20 
rain with labeled F(ab')2 fragments of antilight-chain antibodies. 
:~ Cells minced in presence of 0.1% decomplemented rat serum. 
§ 70 pg/ml rat IgG. 
rabbit  antibodies of various specificities (Table IV).  (The data in Table III are 
not directly comparable  to those in Table IV since the antibodies  used in the 
latter  experiments  did  not have  the  same  specific activity as  those  used  pre- 
viously.)  Compared  to  rabbit  antilight-chain  antibody  or  its  fragments  only 
small amounts  of anti-'r heavy-chain antibody  and nonspecific rabbit  IgG be- 608  IgE-BINDING  BASOPHIL  LEUKEMIA  CELLS 
TABLE IV 
Binding of [1~5I]Rabbit Antibodies and Fragments to Rat Leukemia Basopkils* 
Incubatiz)n  Counts bound/cell X  10  3  Net rabbit  Prelncubation 
(PCA/ml)  [mI]rabbit anti-  Molecular  molecules 
body specificity  foErn  Gross  Net  bound/cell 
320  Light chain  Fab'  8.0  7.4  1,100,000 
O$  ......  1.4  0.8  130,000 
0  ......  0.6  --  -- 
320  "  "  F (ab') ~  34  30  1,500,000 
O~  "  "  "  7.8  3.5  180,000 
0  .....  '  4.3  --  -- 
320  ....  IgG  53  46  1,200,000 
0~  ......  12  4.7  120,000 
0  ....  "  7.3  --  -- 
320  3' Heavy chain  IgG  3.8  2.0  57,000 
O~  ......  4.3  2.5  71,000 
0  "  "  "  1.8  --  -- 
320  None  IgG  1.5  -- 1.9  -- 57,000 
O~  ....  1.3  --2.1  -62,000 
0  ....  3.4  --  -- 
* 8.4 X 106 washed tumor basophils were preincubated with 4 ml of rat reagin dilutions or 
controls at 37°C X I h. and washed three times in cold buffer. Aliquots were then incubated 
with 7.5/zg of labeled rabbit antibody or fragments of known specific activity.  After three 
washes, the pellet was counted and rabbit molecules/cell were calculated. (Net binding to cell 
pellet for Fab', F(ab')2 and IgG antifight chain was 0.16, 0.42, and 0.53/ag, respectively.) 
:~ A dilution of normal serum comparable to the reaginic serum dilution  was used. 
came bound to the sensitized cells. Moreover the anti-')" heavy-chain antibody 
and nonspecific rabbit IgG did not distinguish between cells incubated with 
reaginic or normal serum. 
Direct  Binding  Studies  with  [~5I]IgE.--As  reported elsewhere  8 we have par- 
tially purified IgE from reaginic serum and radiolabeled such preparations with 
~25I. These preparations are free of all immunoglobulins  other than IgE. In the 
experiments reported  here  preparations in which  approximately 50%  of  the 
counts (80% of the IgE-related counts as determined by radioimmunoassay) 
became bound to the leukemia cells at high cell:IgE input ratios (>7  X  106 
cells/PCA U) were used. 
Fig. 2 illustrates a typical binding curve observed when 10 PCA U of [125]IgE 
were incubated with  1.55  X  l0  s cells at 37°C for varying time periods.  The 
specificity of the reaction was determined by adding a variety of inhibitors to 
the incubation mixture before adding the cells and measuring the amount of A. KULCZYCKI~ JR.,  C. ISERSKY, AND H. M_ETZGER  609 
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FIG. 2.  [12~I]IgE binding to cultured basophils.  0.2-ml samples were removed at the times 
indicated from incubation mixtures each of which contained 1.55 X  106 cells and partially 
purified [12sI]IgE(Prep  S, 10 PCA U) in a final volume  of 1.0 ml. Temp. : 37°C. The cross-bars 
indicate the range of values for duplicate samples. 
IgE bound after several time intervals.  Equilibrium results  are tabulated in 
Tables V and VI. Typical data are further illustrated in Fig. 3. 
The  binding  of  the  [l~sI]IgE  was  inhibited  more  than  90%  by adequate 
amounts of reaginic rat serum. Normal rat serum caused only slight inhibition 
and there was no clear-cut dose dependence. Reaginic and normal mouse serums 
gave corresponding results. A mouse reaginic sermn with higher reaginic activity 
(pool II) gave better inhibition than a less active serum (compare Exp. A and 
B, Table V). A purified preparation of a human IgE myeloma failed to inhibit 
the binding of rat IgE significantly (Exp. C, Table V; Fig. 3). 
Reaginic serum which had been heated for 4 h at 56°C and which was devoid 
of 48-h  PCA  activity, failed to  inhibit  the  binding  of  [125I]IgE (Table VI). 
Similarly, reduction and alkylation of a reaginic serum fraction caused a 75 % 
drop in PCA activity compared to a control (in which the reducing and alkylat- 
ing reagents were added in reverse order) and a comparable reduction (71-88 %) 
in inhibitory capacity (Exp. B, Table VI). 
As a further test of the specificity of binding, the partially purified [125I]IgE 
preparation was depleted of immunoglobulin by passing it over a rabbit antirat 
Fab column. Only ~5 %  of the total radioactivity of this material was asso- 
ciated with IgE as determined by radioimmunoassay, and only 7-10 % of the 
counts became bound under conditions where 50% of the counts in the un- 
absorbed preparation were adsorbed by the cells. 610  IgE-BINDING  BASOPHIL  LEUKEMIA  CELLS 
TABLE  V 
Inhibition  of [1251]IgE Binding  by Rodent and Human IgE* 
Exp.  Cells/ml  X  lO-S 
Inhibitor 
Type  Amount 
Percent inhibition  (vs 
buffer  control) 
1.46 
2.86 
C  1.46 
Normal rat serum 
Reaginlc rat serum 
Normal mouse serum 
Reaginic mouse serum I 
Normal rat  serum 
Reaginic rat serum 
Normal mouse serum 
Reaginic mouse serum II 
Human myeloma IgE  (PS) 
~,t/mt 
200  1.2 
40  8.5 
8  15 
200  91 
40  65 
8  28 
200  --3.6 
40  --0.7 
200  49 
40  20 
823  26 
264  --0.7 
68  --18 
14  --6.5 
823  95 
264  88 
68  57 
14  31 
823  16 
264  --3.1 
68  --16 
14  --3.1 
823  84 
264  64 
68  28 
14  19 
rag~rot 
0.99  8.1 
0.10  4.5 
0.01  3.7 
* In Exp. A the cells were incubated with 10 PCA U of [12sI]IgE and either rat normal or 
reaginic  (8,000 PCA/ml) serum, or with mouse normal or reaginic (10,240 PCA/ml) serum. 
In Exp. B  the cells were incubated with 20 PCA U  of [12~I]IgE and either rat normal or re- 
aginic (8,000 PCA/ml) serum, or with mouse normal or reaginic (aggregate of >25,000 PCA/ 
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TABLE VI 
Inhibition  of [1251]IGE Binding  by Heated and Reduced Rat Reaginic Serum* 
Exp. 
Inhibitor  Cells/ml X 10  -6  Percent inhibition 
Type  Amount  vs buffer control) 
A  1.53 
2.82 
ul/ml 
Native normal serum  200  --1.7  (4-1.9):~ 
Heated normal serum  200  -8.6  (4-1.2) 
Native reaginic serum  200  90  (4-0) 
Heated reaginic serum  200  2.2  (4-4.2) 
Native reaginic serum  820  95 
260  88 
68  57 
14  31 
Reduced reaginic serum  260  26 
fraction  130  I0 
66  11 
26  --6.3 
Reduced reaginic serum  260  91 
fraction control  130  85 
66  75 
26  54 
* In Exp. A the cells were incubated with 10 PCA U of [125I]IgE and normal serum (native 
or heated), or heated reaginic serum with no PCA activity, or native reaginic serum  (8,000 
PCA/ml). In Exp. B the cells were incubated with 20 PCA U of [125I]IgE and either reaginic 
(8,000 PCA/ml) serum, or a  reduced  and alkylated  fraction  (<250 PCA/ml), or  a  con- 
trol  (1,000 PCA/ml). 
Range of duplicates. 
DISCUSSION 
The  rat  basophil leukemia line induced by a  fl-chlorethylamine (ICI no. 
42464) and serially transplanted in a  closed colony of Wistar rats (3) has been 
transplanted into eight  other Wistar strains. Transplantation characteristics 
and cell morphology are equivalent to those originally described (3). The cell 
line has been transplanted for over 3 yr in England and for 7 mo in our labora- 
tory  with  no  evidence  of  change.  It  therefore  seems  sufficiently stable  to 
warrant extensive exploration. 
The cells were adapted to a suspension cell culture by routine methods. After 
4 mo in culture, the basophil leukemia cells do not differ in microscopic appear- 
ance or in IgE-binding capacity from either the original cultured cells or the 
minced tumor  cells.  The  cultured  cells  (and frozen  cultured  cells)  initiated 
basophil tumors and leukemia similar to those initiated by tumor minces upon 
subcutaneous injection into newborn rats. 12 
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FIG. 3.  [z25I]IgE  binding to cultured basophils. At the times indicated  samples were taken 
from the incubation mixtures each of which contained: 1.46 X  10 6 cells, partially purified 
[125I]IgE (Prep V, 10 PCA U), 0.2-ml inhibitor and a total volume of 1.0 ml.  Temp.: 37°C. 
The cross-bars  indicate  the range of duplicate points where  taken.  D, rat reaginic  serum 
(8,000 PCA/ml), dilutions  indicated;  {3, mouse reaginic serum (10,240 PCA/ml) undiluted; 
qD, mouse reaginic serum (10,240 PCA/ml) diluted  1:5;  0, human IgE myeloma (PS),  5.0 
mg/ml; O, Tyrode's buffer. 
Both cultured cells and tumor suspensions were found (in collaboration with 
Dr.  R.  Siraganian,  NIDR,  Nil-I)  to contain  0.6-0.9  #g  histamine/10 s  cells. 
This is much lower than the histamine content previously reported for the  cells 
(3)  but is equivalent  to that present in normal human  and monkey basophils 
(11,  12). We do not know the reason for the discrepency between our own and 
Eccleston et al. (3)  results in this respect. It is worth noting that we have not 
so far been able to obtain histamine release either with compound 48/804  (12) 
or with antigen or antilight-chain antibodies using cells preincubated with IgE. 
In addition  to the obvious advantage of cultured  cells  (homogeneity,  mani- 
pulability,  etc.)  these  preparations  are  most  amenable  for  binding  studies. 
While tumor minces routinely showed many broken cells and 30-40 % of intact 
cells were nonviable  the  cultured  cells  appear largely intact  (Fig.  1)  and  are 
routinely 95-100 %  viable. 
Our  experiments  demonstrated  that  these  cells  bind  rat  and  mouse  IgE 
immunoglobulins.  This was ultimately  shown  by direct  binding  studies  using 
4 Compound 48/80 is a condensation product of formaldehyde and p-methoxyphenylethyl- 
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[~5I]IgE, studies which confirmed the interpretations of experiments involving 
PCA depletion and the use of antilight-chain antibody binding. 
The PCA-depleting activity of the rat leukemia cells is considerably greater 
than that described by Minard and Levy for the mouse mastocytoma of Furth 
(10) and confirmed by us (Table II). The activity is similar to that  described 
for purified normal rat peritoneal mast cells as determined by Bach and Brashler 
(13). That cell-conditioned medium did not cause any PCA depletion suggesting 
that the depletion was not simply due to the destruction of IgE antibodies by 
proteases, which might have been released by the cells. That depletion occurred 
in the presence of a 40-fold excess of normal over reaginic serum (Exp. C, Table 
I) testifies to the specificity of the phenomenon. 
Cells incubated with reaginic-serum bound much more rabbit antilight-chain 
antibodies than cells incubated with buffer or normal serum (Tables III and 
IV). The small amount of binding seen in the latter instances could be due to 
some IgE already present on the cells (these experiments were performed before 
the  time  cell  culture  preparations  were  available)  or  due  to  some  residual 
homocytotropic rat  IgG  (14).  No  significant  binding  of normal  rabbit  IgG 
(absorbed on a rat serum protein column to remove potential "natural" anti- 
bodies to rat immunoglobulin) was observed and only an insignificant difference 
in binding between intact rabbit-IgG antibodies, and F(ab~)2 fragments of such 
antibodies was evident (Table IV). This suggests that these cells have little if 
any binding activity for the Fc regions of immunoglobnlins in general. 
The most convincing evidence for specific IgE-binding activity comes from 
the experiments using partially purified [~5I]IgE,  particularly from the inhibi- 
tion of binding studies. The radiolabeled IgE accounts for only an insignificant 
fraction (<0.1%)  of the total protein in those experiments. The binding was 
inhibited by reaginic rat and mouse serums almost completely, but hardly at all 
by normal serums. On the other hand, a purified human IgE myeloma protein 
which was known to bind avidly to human basophils (15), inhibited the binding 
of the rat IgE only slightly if at all.  From the estimated concentration of rat 
IgE  in our reaginic serum pool  (~-~0.14 mg/ml)  3 and  the  relative inhibitory 
activity of that serum and the human IgE, we estimate that the latter is bound 
at least 1,000-fold less avidly than the rat IgE by the leukemic cells. Conflicting 
data on the capacity of normal rat mast cells to bind human IgE have been 
reported (16-20). 
Some IgG immunoglobulins appear to compete for the IgE-binding sites on 
rat and mouse mast cells (13,  19, 20). Our failure to observe inhibition of IgE 
binding by normal  serums may be due  to inadequate  concentrations of the 
relevant IgG subclass in the serums we used or to differences in the receptor on 
the leukemic cells.  Studies are underway to clarify this point. 
Studies with rat mast cells and human blood basophils indicate that  Ca  ++ 
and Mg  ++ are required for IgE-mediated histamine release but not for the initial 
binding of IgE antibodies to the target cells (21,  22). Our studies with the rat 614  IgE-BINDING BASOPHIL LEUKEMIA CELLS 
leukemic cells also indicate that Ca  ++ and Mg  ++ do not influence the binding 
of IgE. 
In all species where IgE-like antibodies have been observed, PCA activity is 
lost when the reaginic serum is heated or reduced; our studies with the leukemic 
cells suggest that this is due to the failure of IgE to bind to the IgE receptors 
(Table VI). Studies with human IgE led to a similar conclusion (24). 
We are presently investigating the binding parameters of the IgE receptors 
on these cells. Our initial studies on the kinetics and concentration dependence 
of binding are consistent with a second order, reversible reaction and more ex- 
tensive  studies  than  are  reported here will  be necessary to  obtain  accurate 
values for the number of receptors for IgE on these cells. However, some of the 
experiments  reported  here  on  PCA  depletion,  anfilight-chain  binding,  and 
[125I]IgE binding  were  performed under roughly equivalent  conditions  (IgE 
and cell concentration, temperature, and time). Furthermore, we can estimate 
the amount of IgE/PCA unit,  8 the number of antilight-chain antibodies which 
can bind to each IgE molecule (see Materials and Methods), and the specific 
activity of our iodinated IgE. We can therefore determine whether the results 
obtained by the three different analyses are consistent with each other. Such 
calculations show that in each instance several hundred thousand molecules of 
IgE became bound/cell. Since these molecules were detected by the antilight- 
chain antibodies, it appears that the major portion of the bound IgE is retained 
on the surface of the cell. Preliminary autoradiographic studies on cells incu- 
bated with  [125I]IgE (performed with  the help of Dr.  A.  Rosenthal,  NIAID, 
NIH) are consistent with this interpretation. These latter studies also indicated 
highly uniform labeling of the cell culture preparation. 
SUMMARY 
A  rat basophilic leukemia cell  line originally described by Eccleston et al. 
(3) has been successfully transplanted into eight Wistar  strains  and  adapted 
to suspension cell culture without noticeable morphological changes. 
The cells deplete the reagiuic activity of mouse and rat immune sera to an 
extent roughly equivalent to that reported for normal rat mast cells.  Studies 
utilizing radioiodinated antilight-chain antibodies and radioiodinated partially 
purified rat IgE indicate that the cells bind IgE to their surface membrane with 
high specificity. Heating or mildly reducing the rat IgE destroyed its binding 
activity. The binding is unaffected by the presence or absence of Ca  ++  and 
Mg  ++, and is markedly inhibited by reaginic but not by normal rat or mouse 
serums. The affinity of these cells for human IgE, if present at all, is substan- 
tially lower than for rat IgE. 
We are grateful to Dr. B. J. Leonard for providing us with tumor, the requisite breeding 
pairs of rats, and advice concerning  tumor transplantation. Dr. Don Buell helped us adapt the 
tumor to suspension culture. Ms. Patricia Minard gave us much useful advice in respect to 
the mouse mastocytoma  experiments.  Dr. Hansen was helpful in regard to providing  us with a A.  KULCZYCK1, JR.,  C.  ISERSKY, AND H.  METZGER  615 
variety of Wistar strain newborn rats. Finally we are much indebted  to Mr. George Poy for 
his dedicated assistance in transplanting  and maintaining the tumors. 
REFERENCES 
1.  Stanworth, D. R., J. H. Humphrey, H. Bennich, and S.  G. O. Johansson.  1968. 
Inhibition of Prausnitz-Ktistner reaction by proteolytic-cleavage fragments of 
a human myeloma protein of immunoglobulin class E. Lancet.  2:17. 
2.  Ishizaka, K., T. Ishizaka, and E. H. Lee. 1970. Biologic function of the Fc frag- 
ments of E myeloma protein. Immunochemislry. 7:687. 
3.  Eccleston,  E., B. J.  Leonard, J.  S. Lowe, and H. J.  Welford.  1973.  Basophilic 
leukaemia in the albino rat and a demonstration of the basopoietin.  Nat.  New 
Biol. 244:73. 
4.  Furth, J.,  P. Hagen, and  E.  Hirsch.  1957. Transplantable  mastocytoma in the 
mouse containing histamine heparin and 5-hydroxytryptamine. Proc.  Soc. Exp. 
Biol. Med. 95:824. 
5.  Dunn, T. B., and M. Potter.  1957. A  transplantable  mast cell neoplasm in the 
mouse. J. Natl. Cancer Inst. 18:587. 
6.  Levine,  B.  B.,  and  N.  M.  Vaz.  1970. Effect of combinations of inbred  strain, 
antigen, and antigen dose on immune responsiveness and reagin production in 
the mouse. Int. Arch. Allergy A ppl. Immunol. 39:156. 
7.  Nisonoff, A., G. Markus, and F. C. Wissler.  1961. Separation of univalent frag- 
ments  of  rabbit  antibody  by reduction  of  a  single,  labile  disulphide  bond. 
Nature (Lond.). 189:293. 
8.  McConahey, P. J., and F. J. Dixon. 1966. A method of trace iodination of proteins 
for immunologic studies. Int. Arch. Allergy A ppl. Immunol. 9.9:185. 
9.  Ogilvie,  B.  M.  1967. Reagin-like  antibodies  in  animals  immune  to  helminth 
parasites. Nature (Zonal.). 204:91. 
10.  Minard,  P.  and D. Levy.  1972. Reaginic antibody receptors  on murine masto- 
cytoma cells. J. Immunol. 109:887. 
11.  Ishizaka, T., K. Ishizaka, and H. Tomioka. 1972. Release of histamine and slow 
reacting  substance  of  anaphylaxis  (SRS-A)  by  IgE-anti-IgE  reactions  on 
monkey mast cells. J. Immunol. 108:513. 
12.  Paton, W. D. M.  1951.  Compound 48/80: A potent histamine liberator.  Br. J. 
Pharmacol.  6:499. 
13.  Bach, M. K., and J. R. Brashler.  1973. On the nature of the presumed receptor 
for IgE mast cells. II. Demonstration of the specific binding of IgE to cell-free 
particulate preparations from rat peritoneal mast cells. J. Immunol. 111:324. 
14.  Bach, M. K., K. J. Bloch, and K. F. Austen. 1971. IgE and IgGa antibody medi- 
ated release of histamine from rat peritoneal cells. II. Interaction of IgGa and 
IgE at the target cell. J. Exp. Med. 133:772. 
15.  Becket, K. E., T. Ishizaka, H. Metzger, K. Ishizaka, and P. M. Grimley. 1973. 
Surface IgE on human basophils during histamine release. J. Exp. Meal. 138:394. 
16.  Perelmutter, L., and A. Liakopoulou. 1971. Detection of IgE mediated immediate 
hypersensitivity reactions in the sera of ragweed sensitive individuals using rat 
mast cells. Int. Arch. Allergy A ppl. Immunol. 40:481. 
17.  Gillman,  S. A., and Z. H. Haddad.  1973. Histamine release from rat peritoneal 616  IgE-BINDING BASOPHIL LEUKEMIA CELLS 
mast cells after passive sensitization with human reaginic serum or E  myeloma 
protein. J. Allergy Clin. Immunol. 50:131. 
18.  Plaut, M., L. M. Lichtenstein, and K. J. Bloch. 1973. Failure to obtain histamine 
release from rat mast cells exposed to human allergic  serum and specific  antigen 
or IgE myeloma protein and anti-IgE. J. Immunol. 111:1022. 
19.  Bach, M. K., J. R. Brashler, and D. J.  Stechschulte.  1973. Isolation of hapten- 
specific antibodies from reagin-rich rat sera and their use for the preparation  of 
rat peritoneal  cells  for antigen-mediated  histamine  release.  Immunochemistry 
10:305. 
20.  Vaz, N. M., and Z. Ovary. 1968. Passive anaphylaxis in mice with ~'G antibodies. 
III. Release of histamine from mast cells by homologous antibodies. J. Imrnunol. 
100:1014. 
21.  Bach, M. K., K. J. Bloch, andK. F. Austen. 1971. IgE andIgGa antibody-mediated 
release  of histamine  from rat  peritoneal  cells.  I.  Optimum  conditions  for in 
vitro preparation of target  cells with antibody and challenge with antigen. J. 
Exp. Med. 133:752. 
22.  Osier,  A. G., L. M. Lichtenstein, and D. A. Levy. 1968. In vitro studies of human 
reaginic allergy. Adv. Immunol. 8:183. 
23.  Ishizaka, K., T. Ishizaka, and A. E. O. Menzel. 1967. Physicochemical properties 
of reaginie antibody. VI Effect of heat on "yE-, ~,G- and ~/A-antibodies  in the 
sera of ragweed sensitive patients. J. Immunol. 99:610. 